Tiziana Life Sciences PLC Issue of Equity (3188M)
April 27 2018 - 2:00AM
UK Regulatory
TIDMTILS
RNS Number : 3188M
Tiziana Life Sciences PLC
27 April 2018
Tiziana Life Sciences plc
("Tiziana" or the "Company")
Issue of equity
27 April 2018
Tiziana Life Sciences plc (AIM: TILS), a clinical stage
biotechnology company developing targeted drugs for cancer and
autoimmune diseases, today announces that it has allotted 23,014
ordinary shares in the Company at a price of 70p per share. This
issue is in relation to a shortfall in capitalized interest due to
a former holder of the Company's Class C Convertible Loan Notes
which was discovered during the annual audit process.
Application will be made to the London Stock Exchange plc to
admit the 23,014 new ordinary shares to trading on AIM. Admission
of the new ordinary shares is expected to occur on or around 3 May
2018. The new ordinary shares will rank pari passu with the
existing ordinary shares.
Following the issue of shares detailed above the so enlarged
issued share capital of the Company will comprise 126,927,299
ordinary shares of 3p each.
Contacts
Tiziana Life Sciences plc
Gabriele Cerrone, Chairman and founder +44 (0)20 7493 2853
Cairn Financial Advisers LLP (Nominated
adviser)
Liam Murray / Jo Turner +44 (0)20 7213 0880
About Tiziana Life Sciences
Tiziana is a UK biotechnology company that focuses on the
discovery and development of novel molecules that treat human
disease in oncology and immunology. The Company is focused on its
lead compound milciclib. The Company is also in clinical
development of foralumab. Foralumab is the only fully human
engineered human anti-CD3 antibody in clinical development. This
phase II compound has potential application in a wide range of
autoimmune and inflammatory diseases, such as nonalcoholic
steatohepatitis (NASH), primary biliary cholangitis (PBS),
ulcerative colitis, multiple sclerosis, type-1 diabetes (T1D),
inflammatory bowel disease (IBD), psoriasis and rheumatoid
arthritis, where modulation of a T-cell response is desirable.
For more information go to
http://www.tizianalifesciences.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEFQLLLVZFFBBZ
(END) Dow Jones Newswires
April 27, 2018 02:00 ET (06:00 GMT)
Tiziana Life Sciences (LSE:TILS)
Historical Stock Chart
From Apr 2024 to May 2024
Tiziana Life Sciences (LSE:TILS)
Historical Stock Chart
From May 2023 to May 2024